A Look At Clorox (CLX) Valuation After Softer Earnings And Cautious Growth Outlook

Fresh analyst commentary and Clorox (CLX) management remarks have pushed the stock back into focus as investors weigh cost inflation, trade down risks, currency headwinds, and a softer outlook for category growth.

See our latest analysis for Clorox.

At a share price of $104.89, Clorox has seen a 3.71% 1 day share price return and a 2.41% 7 day share price return. However, its 1 year total shareholder return of 21.39% and 5 year total shareholder return of 35.24% highlight fading longer term momentum as investors reassess earnings risks after softer EPS and cautious management commentary.

If recent consumer headwinds have you rethinking staples, it could be worth widening your search using a screener focused on 20 top founder-led companies

With Clorox trading at $104.89, screens flag a discount to some valuation estimates. However, recent EPS pressure, cautious growth commentary, and weaker long term returns raise a key question: is this a reset entry point, or is the market already pricing in future growth?

Most Popular Narrative: 12.4% Undervalued

Clorox's most followed narrative pegs fair value at $119.76, above the latest close of $104.89, which puts a spotlight on the assumptions behind that gap.

The updated analyst price target for Clorox has shifted slightly lower to reflect a fair value move from about $122.41 to $119.76. Analysts are factoring in recent target cuts tied to softer guidance, slower expected volume recovery, and modestly lower revenue growth, profit margin, and future P/E assumptions, partially offset by at least one small upward revision.

Read the complete narrative.

Curious what has to happen on revenue, margins, and earnings for that valuation to hold up? The narrative leans on a specific earnings path and a future multiple that closely tracks sector expectations, with only a narrow buffer for disappointment baked in.

Result: Fair Value of $119.76 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, the story can break if sluggish category growth persists or if price competition and heavier promotions keep pressuring Clorox's margins and earnings power.

Find out about the key risks to this Clorox narrative.

Next Steps

If this mix of caution and potential feels familiar, take a closer look at the numbers now and shape your own view with the 4 key rewards and 1 important warning sign.

Looking for more investment ideas?

If you are reassessing Clorox, do not stop here, widen your watchlist with other well filtered ideas that fit your goals before the next move passes you by.

• Target reliable income by checking out 13 dividend fortresses built to spotlight companies offering higher yields with an eye on resilience.
• Seek quality at a discount by using the 62 high quality undervalued stocks to surface businesses that screens flag as both solid and potentially mispriced.
• Prioritise staying power with the 68 resilient stocks with low risk scores and focus on companies where risk metrics point to more resilient profiles.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com